# Surmodics wins FDA approval for SurVeil drug-coated balloon

Surmodics received FDA approval for its SurVeil drug-coated balloon to treat peripheral arterial disease, triggering a $27 million milestone payment from partner Abbott.

- Type: Product launch
- Announced: 2023-06-20
- Where: United States
- Value: $27.0M
- Status: completed
- Products: SurVeil drug-coated balloon
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Surmodics](https://endata.com/companies/30343.md)
- [Abbott](https://endata.com/companies/4479.md) (partner)

## Sources

- [medtechdive.com](https://www.medtechdive.com/news/SRDX-ABT-Surmodics-Abbott-FDA-balloon/653368/), 2023-06-20: "Surmodics said Tuesday it has won Food and Drug Administration approval for the SurVeil drug-coated balloon to treat peripheral arterial disease, clearing the way for the company to receive a $27 million milestone payment from partner Abbott."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.